Literature DB >> 222561

Prevalence of gallbladder disease in hyperlipoproteinemia.

J Ahlberg, B Angelin, K Einarsson, K Hellström, B Leijd.   

Abstract

An analysis of the occurrence of gallbladder disease (ie, cholelithiasis, cholecystitis, cholecystectomy) in 210 consecutive patients with primary hyperlipoproteinemia showed that the prevalence of gallbladder disease was 8%, 18%, and 42% in males with type IIa, IIb, and IV hyperlipoproteinemia, and 22%, 48%, and 72% in the corresponding groups of females. The 40-59-year-old patients were compared to three necropsy series from Malmö, Sweden. The occurrence of gallbladder disease was within normal limits in type IIa and abnormally high in type IV hyperlipoproteinemia. There were no differences with regard to age, body weight, glucose intolerance, or ischemic heart disease between type IV patients with and without GBD. It is suggested that certain forms of disturbances of lipoprotein metabolism are associated with an increased risk for development of gallbladder disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222561     DOI: 10.1007/bf01299828

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  On the intravenous glucose tolerance test.

Authors:  D IKKOS; R LUFT
Journal:  Acta Endocrinol (Copenh)       Date:  1957-07

2.  Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.

Authors:  D Pertsemlidis; D Panveliwalla; E H Ahrens
Journal:  Gastroenterology       Date:  1974-04       Impact factor: 22.682

Review 3.  Classification of hyperlipidaemias and hyperlipoproteinaemias.

Authors:  J L Beaumont; L A Carlson; G R Cooper; Z Fejfar; D S Fredrickson; T Strasser
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Atherosclerosis in a defined population. An autopsy survey in Malmö, Sweden.

Authors:  N H Sternby
Journal:  Acta Pathol Microbiol Scand       Date:  1968

5.  Letter: Clofibrate and gallstones.

Authors:  J Cooper; H Geizerova; M F Oliver
Journal:  Lancet       Date:  1975-05-10       Impact factor: 79.321

Review 6.  Bile composition, bile salt metabolism and gallstones.

Authors:  R N Redinger; D M Small
Journal:  Arch Intern Med       Date:  1972-10

7.  The epidemiology of gallbladder disease: observations in the Framingham Study.

Authors:  G D Friedman; W B Kannel; T R Dawber
Journal:  J Chronic Dis       Date:  1966-03

8.  Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project.

Authors: 
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

9.  Elimination of cholesterol in hyperlipoproteinaemia.

Authors:  B Angelin; K Einarsson; K Hellström; M Kallner
Journal:  Clin Sci Mol Med       Date:  1976-10

10.  Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;.

Authors:  K Einarsson; K Hellström; M Kallner
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  14 in total

1.  Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.

Authors:  I J A M Jonkers; A H M Smelt; M Ledeboer; M E Hollum; I Biemond; F Kuipers; F Stellaard; R Boverhof; A E Meinders; C H B W Lamers; A A M Masclee
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Risk factors for gallstone formation during rapid loss of weight.

Authors:  H Yang; G M Petersen; M P Roth; L J Schoenfield; J W Marks
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

3.  The sweet road to gall stones.

Authors:  K W Heaton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

4.  Gallbladder disease and hyperlipoproteinemia.

Authors:  M C Bateson
Journal:  Dig Dis Sci       Date:  1980-04       Impact factor: 3.199

5.  Pregnancy is not a risk factor for gallstone disease: results of a randomly selected population sample.

Authors:  Thomas Walcher; Mark Martin Haenle; Martina Kron; Birgit Hay; Richard Andrew Mason; Alexa Friederike Alice von Schmiesing; Armin Imhof; Wolfgang Koenig; Peter Kern; Bernhard Otto Boehm; Wolfgang Kratzer
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

6.  Retinol-binding protein 4 as a risk factor for cholesterol gallstone formation.

Authors:  Tao Han; Diancai Zhang; Zan Fu; Yueming Sun; Wei Yang; Cuimei Yuan
Journal:  Mol Cell Biochem       Date:  2013-02-19       Impact factor: 3.396

7.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

8.  Effects of dietary sucrose on factors influencing cholesterol gall stone formation.

Authors:  D Werner; P M Emmett; K W Heaton
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

9.  Low-dose chenodeoxycholic acid for gallstone dissolution: a randomized trial in poor operative risk patients.

Authors:  R G Danzinger; T K Kurtas; M G Torchia
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

10.  Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma.

Authors:  P Henriksson; K Einarsson; A Eriksson; U Kelter; B Angelin
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.